National Commodity & Derivatives Exchange Ltd. Unlisted Shares
NCDEX Unlisted Shares — Price, FY26 Results & the Big Pivot
India’s largest agri-commodity exchange is attempting one of the boldest reinventions in the unlisted space: armed with fresh capital and SEBI’s in-principle nod, NCDEX is preparing to enter the equity and equity-derivatives business. Here’s the complete, honest picture before you buy or sell.
| NCDEX Unlisted Share | Details |
| Our Buy Price | ₹320 per share |
| Our Sell Price | ₹360 per share |
| Lot Size | 100 shares (min. investment ≈ ₹36,000) |
| ISIN | INE127G01010 |
| Incorporated | 23 April 2003 |
| Demat | NSDL & CDSL (off-market transfer) |
| Price last updated | {Date} — confirm live quote before trading |
[Get Live NCDEX Quote on WhatsApp] [Sell Your NCDEX Shares]
About NCDEX
Incorporated in 2003, National Commodity & Derivatives Exchange Ltd was India’s first fully computerised agri-commodity exchange and still commands roughly 82% of India’s agri-commodities derivatives trading. It offers futures and options across guar, spices, oilseeds and other agricultural complexes, and runs an integrated ecosystem: clearing through NCCL, electronic warehouse receipts (eNWRs) through NERL, and agri e-market platforms. Its institutional pedigree is a key attraction — shareholders include LIC, NSE, NABARD, Canara Bank and Punjab National Bank.
NCDEX Financials — The Honest Picture (FY24–FY26)
| Particulars | FY24 | FY25 | FY26 (9M/H1 trend) |
| Revenue from Operations | ₹95.7 Cr | ₹88.2 Cr | H1: ₹39 Cr (flat YoY) |
| Net Profit / (Loss) | — | ₹234 Cr* | Q3: ₹(8.5) Cr loss, narrowing |
The FY25 profit was driven overwhelmingly by one-time exceptional gains (including asset sales and a Core SGF refund) — not operations. Operationally, NCDEX remains loss-making: H1 FY26 showed an EBITDA loss of ₹51 crore, though Q3 FY26 losses narrowed to ₹8.5 crore from ₹11.8 crore in Q2.
Why the core business is under pressure: trading suspensions in key commodities (chana, mustard — and earlier pulses and spices that once drove ~70% of volumes) have been extended to March 31, 2026, gutting transaction revenue.
Why investors still care — the balance sheet and the pivot:
- Cash-rich: roughly ₹700 crore in cash plus ₹308 crore in investments; shareholders’ equity has climbed to ~₹863 crore. No financial distress.
- ₹770 crore war chest: in October 2025 NCDEX raised ₹770 crore via preferential issue at ₹197.34 per share to fund its entry into equity and equity-derivatives trading.
- SEBI’s in-principle approval is in hand for the new equity segment — a potential transformation from a struggling commodity-only exchange into a third equity exchange challenging the NSE–BSE duopoly.
NCDEX IPO Outlook
An NCDEX IPO has been discussed for years and market reporting suggests the board is working toward listing readiness, with a possible IPO in 2026 subject to regulatory approval — but no current DRHP is on record. Treat all timelines as indicative. Note the preferential issue price of ₹197.34 (October 2025) as a genuine institutional price marker against today’s market band.
Why Investors Buy NCDEX Unlisted Shares
- Exchange licences are scarce, regulated assets — you cannot simply start a new one.
- Deep-pocketed institutional shareholders (LIC, NSE, NABARD, PSU banks).
- The equity-segment pivot offers genuine optionality at a modest market cap (~₹2,400–2,500 crore as of early 2026).
- Commodity suspensions, if lifted, restore the core business almost overnight.
Key Risks — Read Before You Buy
- Operationally loss-making today; the FY25 headline profit was one-time gains, not business strength.
- Execution risk on the equity pivot — it must compete with NSE and BSE’s entrenched liquidity.
- Regulatory dependence — suspended commodities may not return on schedule.
- No confirmed IPO; your holding period could be long, and the 6-month post-listing lock-in will apply to pre-IPO buyers when a listing happens.
How to Buy or Sell NCDEX Unlisted Shares
Get our live quote → confirm the deal → complete KYC (PAN, CML, bank proof) → off-market demat transfer with same/next-day settlement. Full process on our buy unlisted shares page — or if you’re holding NCDEX and want liquidity, see sell unlisted shares.
FAQs — NCDEX Unlisted Shares
What is the NCDEX unlisted share price today?
We are currently buying at ₹320 and selling at ₹360 per share (lot of 100). Private-market prices move with news — WhatsApp us for a live quote.
Is NCDEX profitable?
Not operationally at present. FY25’s ₹234 crore profit came mainly from one-time gains; core operations posted losses through FY26, though quarterly losses have been narrowing.
When is the NCDEX IPO?
Reports point to IPO readiness efforts and a possible 2026 listing, but no DRHP is currently on record with SEBI. Nothing is binding until offer documents are filed.
Why did NCDEX raise ₹770 crore?
Primarily to fund its SEBI-approved entry into the equity and equity-derivatives segment — a strategic pivot beyond agri-commodities.
What is the minimum investment in NCDEX unlisted shares?
One lot of 100 shares — approximately ₹36,000 at our current sell price.
Related unlisted shares: NSE • MSEI • Power Exchange India (PXIL) • ICEX
